Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03957954
PHASE1

Stem Cell Therapy for Limbal Stem Cell Deficiency

Sponsor: University of California, Los Angeles

View on ClinicalTrials.gov

Summary

This phase I study will collect preliminary information on the activity and safety of cLSC. We will investigate the ability to manufacture and transplant cLSC onto the cornea successfully at the time of surgery (feasibility), and have cLSC begin to populate the ocular surface (efficacy) without serious adverse events (safety).

Official title: Safety and Feasibility of Cultivated Autologous Limbal Stem Cells (cLSC) for Limbal Stem Cell Deficiency

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2020-09-30

Completion Date

2027-04-30

Last Updated

2026-02-10

Healthy Volunteers

No

Interventions

BIOLOGICAL

cLSC

Transplantation of cLSC

DEVICE

Scleral contact lens (SCL)

Scleral contact lens device (SCL) will be used to stabilize and improve ocular surface.

Locations (1)

University of California

Los Angeles, California, United States